Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), sold 875 shares at $170.40 ($150K) on 2019-05-29, disclosed to the SEC on 2019-05-29.
Open-market sale of $150k SAGE by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $170.40 | 400 | $68K | 45.6% |
| 2 | $171.39 | 475 | $81K | 54.4% |
| Total | $170.94 avg | 875 | $150K | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |